| 英文别名： |
quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;Cabozantinib;Cabozantinib malate (XL184);(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1);1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,(2S)-2-hydroxybutanedioic acid;Cabozantinib L-Malate Salt;Cabozantinib S-malate;XL-184 L(-)-Malic acid salt;Cabozantinib malate;Cabozantinib malate salt;cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxyquinoline-4-yloxy)phenyl]amide (4-fluoro-phenyl)amide (L)-malate salt;cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide L-malate;N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-d;Smalate;UNII-DR7ST46X58;XL184;XL-184 |
沪公网安备31011402010658号 
(%5bH%5d)%5bC%40%5d1(%5bH%5d)C(%5bH%5d)(%5bH%5d)C(%5bH%5d)(%5bH%5d)C(%5bH%5d)(%5bH%5d)C(%5bH%5d)(%5bH%5d)%5bC%40%40%5d1(%5bH%5d)C(%5bH%5d)(%5bH%5d)%5bH%5d)
